This week’s AI in Healthcare and Digital Health update highlights expanding healthcare AI infrastructure, growing clinical validation efforts, advances in AI-driven drug discovery, and wider adoption of remote monitoring and digital health platforms.
In Today’s Newsletter
Dive deeper
💬 UK adults use AI chatbots instead of GP visits [1] [UK • 21 May 2026]
Context: King’s College London analysed a March 2026 poll of 2,083 UK adults aged 18+.
Key point: One in seven UK adults said they prefer AI chatbots for healthcare advice instead of seeing a doctor.
Implication: Could streamline access to information, but safety depends on users seeking professional care when needed.
⌚ Apple adds health monitoring features [2] [22 May 2026]
https://www.digitalhealthnews.com/apple-rolls-out-latest-health-monitoring-features
Context: Apple is adding blood pressure trend tracking and sleep apnea detection to Apple health tools, including Apple Watch.
Key point: The blood pressure feature is expected to flag trends, not replace medical-grade devices.
Implication: May expand screening, initiation, and follow-up at scale.
🧬 Eli Lilly backs Korea AI drug discovery hub [3] [Korea • 22 May 2026]
https://www.dongascience.com/en/news/78054
Context: Eli Lilly plans Gateway Lab Korea in Songdo, with completion targeted for 2027.
Key point: Lilly said it will invest $500 million in Korea over five years and give resident startups access to Tune Labs.
Implication: Signals pipeline investment and modality expansion.
🎓 Healio and NPACE bring AI into CME [4] [22 May 2026]
Context: Healio AI will be incorporated into NPACE’s in-person and on-demand learning platforms.
Key point: The partnership aims to support advanced practice provider education using clinician-centered AI.
Implication: Could inform practice and payer discussions; interpretation depends on source quality and workflow adoption.
💉 Niagen Plus launches clinician-directed telehealth kit [5] [US • 22 May 2026]
https://www.trendhunter.com/amp/trends/cliniciandirected-telehealth-platform
Context: Niagen Plus uses online intake and licensed-provider consultation for eligible US patients.
Key point: If prescribed, patients receive a prescription-only at-home injection kit with pharmaceutical-grade Niagen.
Implication: Could streamline initiation and adherence via remote prescribing and logistics.
🧬 QIAGEN and NVIDIA expand AI drug discovery [6] [Global • 22 May 2026]
https://www.digitalhealthnews.com/qiagen-partners-with-nvidia-to-expand-ai-drug-discovery
Context: QIAGEN will integrate NVIDIA accelerated computing and NVIDIA BioNeMo into QIAGEN Digital Insights.
Key point: The partnership targets data analysis, biomarker discovery, target identification, drug repurposing, pathway analysis, and hypothesis generation.
Implication: Signals pipeline investment and modality expansion.
🎗️ Artera brings multimodal AI cancer data to ASCO 2026 [7] [US • 21 May 2026]
Context: Artera will present breast and prostate cancer abstracts at ASCO 2026, May 29–June 2 in Chicago.
Key point: Presentations cover multimodal AI risk stratification, chemotherapy benefit prediction, and comparison with genomic risk tools.
Implication: May influence prescriber choice and payer reviews pending full data.
❤️ Medtronic opens Galway cardiac software hub [8] [Ireland • 22 May 2026]
https://www.mpo-mag.com/breaking-news/medtronic-unveils-european-software-development-hub-in-galway/
Context: Medtronic established a European software development hub in Galway for its Patient Care Systems business.
Key point: The hub will support software for cardiac digital health and care of patients with implanted cardiac devices.
Implication: May expand screening, initiation, and follow-up at scale.
⌚ Abbott deepens diagnostics and wearable push [9] [23 May 2026]
Context: Abbott is expanding health technology efforts around diagnostics, wearables, Lingo, and cardiovascular R&D.
Key point: The company is positioning digital health and data-driven care as part of its longer-term device and diagnostics strategy.
Implication: Could inform practice and payer discussions; interpretation depends on adoption, reimbursement, and clinical use.
⚖️ Twin Health launches GLP-1 stewardship model [10] [US • 21 May 2026]
https://hitconsultant.net/2026/05/21/twin-health-launches-glp1-stewardship-ai-model/
Context: Twin Health’s model uses AI Digital Twin technology, lab work, smart scales, CGMs, and activity trackers.
Key point: The platform aims to guide GLP-1 eligibility, monitoring, tapering, and long-term discontinuation through biometric feedback.
Implication: Could streamline initiation and adherence via remote prescribing and logistics.
🧠 BMS and Anthropic deploy Claude across pharma operations [11] [Global • 22 May 2026]
Context: Bristol Myers Squibb will deploy Claude to more than 30,000 employees across research, manufacturing, and commercial functions.
Key point: BMS plans to use Claude and Claude Code for drug discovery, software development, trial documentation, manufacturing workflows, and commercial data.
Implication: Signals pipeline investment and modality expansion.
🍼 MyOr expands AI infant allergy prediction in Australia [12] [Australia • 20 May 2026]
https://www.australianjewishnews.com/israeli-ai-predicts-baby-allergies-before-they-appear/
Context: MyOr uses a model trained on data from one million children and a questionnaire covering family history, environmental exposure, and infant skin biomarkers.
Key point: The platform identifies infants at higher risk of food allergy before symptoms and refers families for dietitian-led intervention.
Implication: May expand screening, initiation, and follow-up at scale.
🏥 Abu Dhabi and Johnson & Johnson launch AI surgical network [13] [UAE • 22 May 2026]
Context: Abu Dhabi Department of Health will connect operating rooms across Cleveland Clinic Abu Dhabi, PureHealth, Mediclinic Group, and NMC Healthcare.
Key point: The network will use Johnson & Johnson’s Polyphonic open digital ecosystem with partners including AWS, NVIDIA, and Core42.
Implication: May expand screening, initiation, and follow-up at scale.
🎯 Plus Therapeutics adds AI execution layer for CNS oncology [14] [US • 19 May 2026]
Context: Plus Therapeutics is developing targeted radiotherapeutics for CNS cancers, including leptomeningeal metastases and recurrent glioblastoma.
Key point: Ephemeral Technologies will help deploy an AI-native platform to integrate therapeutic, diagnostic, and bioinformatics datasets.
Implication: Signals pipeline investment and modality expansion.
📈 Glucose tracking becomes a health data platform [15] [21 May 2026]
https://www.techrepublic.com/article/news-ai-glucose-monitors-wellness-wearables/
Context: TechRepublic reports that CGMs are moving beyond diabetes care into wellness, sports, and preventive health use cases.
Key point: AI platforms are using glucose, sleep, stress, activity, and meal data to support prediction, coaching, and metabolic profiling.
Implication: Could inform practice and payer discussions; interpretation depends on study design, validation, and clinical guidance.
🔬 AI science assistants tackle drug retargeting tasks [16] [19 May 2026]
Context: Nature published papers on Google Co-Scientist and FutureHouse Robin, two agentic AI systems for biological hypothesis generation.
Key point: Both systems supported drug-retargeting tasks by searching literature, forming hypotheses, and using human expert review.
Implication: Signals pipeline investment and modality expansion.
🧾 NHS SBS launches £900m healthcare AI framework [17] [UK • 19 May 2026]
https://www.digitalhealth.net/2026/05/nhs-sbs-launches-900m-healthcare-ai-solutions-framework/
Context: NHS Shared Business Services launched a framework for NHS and public-sector AI procurement.
Key point: The framework covers diagnostics, predictive analytics, robotics, operational efficiency, research, advisory services, and integrated solutions.
Implication: May expand screening, initiation, and follow-up at scale.
🎙️ Voice ML classifies Parkinson’s, COPD, and controls [18] [19 May 2026]
https://www.nature.com/articles/s41598-026-53409-3
Context: The study used sustained vowel “a” recordings from Swedish-speaking COPD and English-speaking Parkinson’s disease cohorts.
Key point: A soft-voting ML classifier achieved 0.842 accuracy and 0.839 macro F1 on an independent participant-disjoint test set.
Implication: Could inform practice and payer discussions; interpretation depends on study design and clinical validation.
🏥 GPT-4o discharge summaries improve patient activation [19] [Germany • 18 May 2026]
https://www.thelancet.com/journals/landig/article/PIIS2589-7500(26)00014-2/fulltext
Context: A single-centre, single-blind RCT at Helios University Hospital Wuppertal randomised 128 adults at discharge.
Key point: GPT-4o-generated patient-oriented discharge summaries improved PAM-13 patient activation scores versus standard summaries.
Implication: May expand screening, initiation, and follow-up at scale.
📊 Predictive AI framed as a therapy ROI multiplier [20] [US • 20 May 2026]
https://ai.nejm.org/doi/full/10.1056/AIpc2600139
Context: The NEJM AI perspective discusses predictive AI for treatment allocation across clinical, biomarker, imaging, and administrative domains.
Key point: The article argues predictive AI can improve risk-based and response-based targeting, reducing effective numbers needed to treat.
Implication: Could inform practice and payer discussions; interpretation depends on model governance, incentives, and regulatory pathways.
📝 AI scribes raise privacy and data-retention questions [21] [US • 20 May 2026]
https://ai.nejm.org/doi/full/10.1056/AIpc2501401
Context: NEJM AI reviews privacy issues as AI scribes capture encounter audio, generate transcripts, and produce structured clinical notes.
Key point: Vendor practices vary in retention, deletion, and whether audio or transcripts are used for AI training.
Implication: Could inform practice and payer discussions; interpretation depends on governance, consent, and legal requirements.
👁️ iPad eye tracking supports Parkinson’s assessment [22] [19 May 2026]
https://www.nature.com/articles/s41746-026-02753-9
Context: Researchers compared iPad-based eye tracking with EyeLink 1000 Plus in 19 healthy controls and 12 patients with Parkinson’s disease.
Key point: A three-metric iPad classifier reported AUROC 0.98, sensitivity 0.91, specificity 1.00, and accuracy 0.96.
Implication: May expand screening, initiation, and follow-up at scale.
📱 FDA-authorized DTx evidence varies widely [23] [US • 20 May 2026]
https://www.nature.com/articles/s41746-026-02737-9
Context: Researchers reviewed 45 FDA-authorized digital therapeutics with authorization decisions from 2019–2022.
Key point: Evidence varied from extensive dossiers to none; half had no available results before authorization.
Implication: Could inform practice and payer discussions; interpretation depends on study design and evidence transparency.
❤️ XGBoost predicts CVD risk in hypertension [24] [21 May 2026]
https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001441
Context: A single-center retrospective study followed 3,588 hypertensive patients free of CVD at baseline for a mean of 8.3 years.
Key point: XGBoost achieved 86% ROC AUC, 81% sensitivity, and 78% specificity; antihypertensive drug count was the strongest predictor.
Implication: Could inform practice and payer discussions; interpretation depends on study design and clinical validation.
🫁 ML models predict lung cancer mortality [25] [21 May 2026]
https://journals.sagepub.com/doi/10.1177/20552076261440650
Context: The study analyzed 24,472 lung cancer patients from Korea’s National Hospital Discharge Injury Survey.
Key point: XGBoost and neural networks showed superior test-set performance; key predictors included admission route, length of stay, and surgery status.
Implication: Could inform practice and payer discussions; interpretation depends on study design and confounding control.
🧑🚀 Metaverse program supports spina bifida transition [26] [Korea • 23 May 2026]
https://journals.sagepub.com/doi/10.1177/20552076261455147
Context: Eight Korean adolescents with spina bifida completed a four-week metaverse-based program.
Key point: Retention was 100%, satisfaction was high, and interviews suggested improved self-management awareness and emotional support.
Implication: May expand screening, initiation, and follow-up at scale.
⌚ Samsung Health may add AI Health Index [27] [Korea • 22 May 2026]
https://www.mk.co.kr/en/business/12055832
Context: Samsung is reportedly reviewing a Samsung Health update around July or August.
Key point: The Health Index would use AI to combine sleep, stress, recovery, activity, heart rate, blood oxygen, and wearable data into a single score.
Implication: Could streamline initiation and adherence via remote prescribing and logistics.
🏙️ Shanghai showcases AI-enabled public health system [28] [China • 23 May 2026]
Context: Shanghai CDC described AI-enabled public health practices at a Geneva conference during the 79th World Health Assembly.
Key point: The system uses big data, knowledge graphs, retrieval-augmented generation, multi-agent technology, and vertical-specific LLMs for risk identification, warning, and intervention.
Implication: May expand screening, initiation, and follow-up at scale.
🔬 AI agent teams accelerate drug-repurposing research [29] [19 May 2026]
https://www.nature.com/articles/d41586-026-01596-4
Context: Nature covered Google Co-Scientist and FutureHouse Robin, two systems using AI agents to develop hypotheses, propose experiments, and analyze data.
Key point: In drug-repurposing tasks, Co-Scientist identified candidate AML drugs, while Robin identified ripasudil as a candidate for dry age-related macular degeneration.
Implication: Signals pipeline investment and modality expansion.
🔎 Google brings agents and generative UI into Search [30] [Global • 19 May 2026]
https://blog.google/products-and-platforms/products/search/search-io-2026
Context: Google announced Search updates at I/O 2026, including Gemini 3.5 Flash as the default model in AI Mode globally.
Key point: Search will add information agents, agentic booking, agentic coding, custom dashboards, generative UI, and expanded Personal Intelligence.
Implication: Could streamline initiation and adherence via remote prescribing and logistics.
🧪 Gemini for Science adds AI research tools [31] [23 May 2026]
https://ai.google/gemini-for-science/
Context: Google described science-focused AI tools spanning Google Labs and Google Antigravity.
Key point: Tools include Literature Insights, Hypothesis Generation, Computational Discovery, and science workflows that condense multi-step analysis pipelines.
Implication: Signals pipeline investment and modality expansion.
Why it matters
- Healthcare AI is shifting from pilots to infrastructure. NHS procurement, Abu Dhabi’s surgical network, Shanghai CDC’s public health platform, and BMS’s Claude rollout show AI becoming a system-wide operating layer. [11,13,17,28]
- AI is moving deeper into clinical decision support, from cardiovascular risk prediction and lung cancer mortality modeling to Parkinson’s voice and eye-tracking biomarkers. These tools could improve targeting, but clinical validation remains the gating issue. [18,22,24,25]
- Drug discovery and life-sciences AI are becoming more agentic. QIAGEN–NVIDIA, Eli Lilly Korea, Plus–Ephemeral, Google Co-Scientist, FutureHouse Robin, and Gemini for Science all point toward AI systems that search evidence, generate hypotheses, and support research workflows. [3,6,14,16,29,31]
- Consumer health and remote monitoring are converging. Apple, Abbott, Samsung Health, CGMs, Twin Health, Niagen Plus, and MyOr show the same direction: more biometric data, more personalized risk signals, and more care pathways outside traditional clinics. [2,5,9,10,12,15,27]
- Evidence quality is now the bottleneck. The DTx evidence map, AI scribe privacy analysis, and GPT-4o discharge summary RCT show that adoption depends on transparent validation, data governance, consent, and post-market evidence. [19,21,23]
- AI may change how healthcare value is measured. Predictive AI can target therapies to patients most likely to benefit, while GLP-1 stewardship and digital therapeutics show how payers and employers may scrutinize ROI, adherence, and outcomes more closely. [10,20,23]
- Human oversight remains central. Across chatbots, surgical AI, AI science agents, discharge summaries, and public health systems, the strongest use cases position AI as decision support, not autonomous medical authority. [1,13,16,19,28,29]
📚 Find your one-stop page for the full AI and Digital Health archive.
🚀 Accelerate your success. Contact us now
📂 Explore our case studies. See examples of our work.
💡 Read our insights. Learn from our latest reports and analysis
🧰 See our full range of services. Discover how we can help you.
Why are UK patients using AI chatbots instead of seeing a GP?
King’s College London found UK adults are using AI chatbots for health advice because of convenience, curiosity, and uncertainty about whether they need a GP appointment. This matters for pharma and healthcare teams tracking patient journey disruption and digital front-door behavior. [1]
What new Apple health monitoring features could affect digital health strategy?
Apple is reported to be adding blood pressure trend tracking and sleep apnea detection to its health tools. The features are positioned for monitoring and alerts, not as replacements for medical-grade diagnostic devices. [2]
How is Eli Lilly using AI drug discovery in South Korea?
Eli Lilly described Korea investment plans, Gateway Lab Korea in Songdo, and access to Tune Labs. Korean startups in Gateway Lab may use Lilly’s AI platform to assess candidate efficacy and side effects. [3]
What does the Healio and NPACE AI education partnership mean for clinicians?
Healio partnered with Nurse Practitioner Associates for Continuing Education to integrate Healio AI into NPACE’s in-person and on-demand education platforms. This could affect how advanced practice providers access AI-supported clinical education. [4]
What is Niagen Plus and how does its telehealth model work?
Niagen Bioscience launched Niagen Plus, a clinician-directed telehealth platform for eligible US patients. The model supports remote intake, provider consultation, and pharmacy shipment of a prescription-only injection kit. [5]
How are QIAGEN and NVIDIA using AI for target identification and biomarker discovery?
QIAGEN will integrate NVIDIA accelerated computing and BioNeMo into QIAGEN Digital Insights. The collaboration targets workflows such as target identification, biomarker discovery, pathway analysis, and hypothesis generation. [6]
What Artera AI oncology data will be presented at ASCO 2026?
Artera will present multimodal AI abstracts in breast and prostate cancer. The breast cancer work includes node-positive HR+ chemotherapy benefit and concordance with a 21-gene recurrence test.
Why did Medtronic open a European software hub in Galway?
Medtronic opened a European software development hub in Galway for Patient Care Systems. The hub will support cardiac digital health software and create 85 initial roles. [8]
How is Abbott expanding its digital health and wearables strategy?
Abbott is expanding diagnostics and wearables, including Lingo biomarker device coverage in the source. The article frames Abbott’s cardiovascular R&D and digital health push as part of a data-driven care strategy.
What is Twin Health’s GLP-1 Stewardship Model?
Twin Health launched a GLP-1 Stewardship Model using its AI Digital Twin platform and biometric data streams. The model is described as supporting clinical oversight for GLP-1 duration, tapering, and discontinuation. [10]
How is Bristol Myers Squibb deploying Anthropic Claude across pharma operations?
Bristol Myers Squibb entered an enterprise agreement with Anthropic to deploy Claude to more than 30,000 employees. BMS plans to use Claude across research, manufacturing, commercial operations, software development, and data integration. [11]
How does MyOr use AI to predict infant food allergies before symptoms appear?
MyOr, an Israeli digital health company expanding in Australia, uses an AI model trained on data from children. The platform identifies infants at high risk of food allergies and refers them for dietitian-led intervention. [12]
What is Abu Dhabi’s intelligent surgical network with Johnson & Johnson?
The Department of Health Abu Dhabi announced an emirate-wide intelligent surgical network with Johnson & Johnson. The AI-native network will connect operating rooms across Cleveland Clinic Abu Dhabi, PureHealth, Mediclinic Group, and NMC Healthcare. [13]
What is Plus Therapeutics building with Ephemeral Technologies in CNS oncology?
Plus Therapeutics partnered with Ephemeral Technologies to deploy an AI-native execution platform for CNS oncology. The platform will integrate therapeutic, diagnostic, and bioinformatics datasets across Plus’ CNS oncology programs.
Why is glucose tracking becoming an AI-powered health data platform?
TechRepublic covered continuous glucose monitors, AI platforms, and wearable sensors moving beyond diabetes care. The source frames glucose sensors as data systems for predictive analytics, personalized coaching, and broader wellness use. [15]
How are teams of AI agents accelerating biomedical research and drug repurposing?
A: Nature covered AI co-scientist systems that use teams of AI agents to develop hypotheses, propose experiments, and analyse data. Google Co-Scientist and FutureHouse Robin identified plausible drug-repurposing candidates with human input and lab follow-up. [16]
What does the NHS SBS £900m healthcare AI framework cover?
NHS Shared Business Services launched a healthcare AI procurement framework for NHS and public-sector organisations. The framework covers diagnostics, predictive analytics, robotics, operational efficiency, research, advisory services, and integrated AI solutions. [17]
Can voice machine learning classify Parkinson’s disease and COPD?
A Scientific Reports study tested sustained vowel recordings from Parkinson’s disease, COPD, and healthy-control cohorts. A soft-voting machine learning model reported multiclass discrimination using acoustic features and explainability analysis. [18]
Do GPT-4o-generated discharge summaries improve patient activation?
The Lancet Digital Health published a single-centre, single-blind randomized trial at Helios University Hospital Wuppertal. GPT-4o-generated patient-oriented discharge summaries improved patient activation versus standard discharge summaries. [19]
How can predictive AI improve therapy ROI and treatment allocation?
NEJM AI discussed predictive AI models for treatment allocation across heterogeneous clinical populations. The article argues that risk-based and response-based targeting can reduce effective NNT and improve ROI for therapies. [20]
What privacy risks should health systems consider before deploying AI scribes?
NEJM AI reviewed AI scribes used to document patient–physician encounters in US health systems. The article highlights privacy risks, vendor differences in data retention, and whether data are used for AI training. [21]
Can iPad eye tracking support Parkinson’s disease screening and monitoring?
An npj Digital Medicine study compared iPad-based eye tracking with a clinical-grade EyeLink system. The iPad-based classifier supported Parkinson’s disease versus healthy-control discrimination in a small convenience sample. [22]
What evidence supports FDA-authorized digital therapeutics?
An npj Digital Medicine study mapped evidence for FDA-authorized digital therapeutics with decisions from 2019–2022. Evidence varied widely, with some products having limited or no publicly available results before authorization. [23]
Can XGBoost predict new-onset cardiovascular disease in hypertension patients?
PLOS Digital Health reported a retrospective study of hypertensive patients without cardiovascular disease at baseline. An XGBoost model outperformed SCORE2 in identifying patients who later developed cardiovascular events. [24]
Which machine learning models best predict lung cancer mortality risk?
DIGITAL HEALTH analysed Korea National Hospital Discharge Injury Survey data for lung cancer patients. XGBoost and neural network models performed best in the test set, with admission route, length of stay, and surgery status as key predictors. [25]
Can a metaverse program support healthcare transition for adolescents with spina bifida?
DIGITAL HEALTH reported a pilot metaverse-based program for Korean adolescents with spina bifida. All eight participants completed the four-week program, with high satisfaction and qualitative gains in self-management awareness. [26]
What is Samsung Health’s planned AI-based Health Index?
MK reported that Samsung Electronics is reviewing a Health Index feature for Samsung Health. The feature would use AI to combine wearable data such as sleep, stress, recovery, activity, heart rate, and blood oxygen into a health score. [27]
How is the EU using AI screening for cancer and cardiovascular disease?
Euractiv covered European Commission plans to expand AI-powered medical screening centres. The EU aims to support imaging-based AI for cancer and cardiovascular disease while addressing limited access to representative European datasets. [28]
What AI-enabled smart healthcare practices did Shanghai share at the Geneva conference?
City News Service reported Shanghai’s smart healthcare practices at a Geneva conference linked to the World Health Assembly. Shanghai described AI-enabled public health tools using big data, knowledge graphs, RAG, multi-agent systems, and digital twin models. [29]
How could Google’s AI Search changes affect healthcare information discovery?
Google announced new AI Search capabilities at I/O, including an upgraded AI Mode and AI-powered Search box. Google said Gemini 3.5 Flash would become the default model in AI Mode globally, with agent-style search features. [30]
Entities / Keywords
AI in healthcare, healthcare AI, clinical AI, generative AI, agentic AI, predictive AI, digital health, life-sciences AI
King’s College London, AI chatbots, health advice, GP access, NHS, patient triage, digital front door
Apple, Apple Health, Apple Watch, blood pressure trends, sleep apnea detection, consumer health monitoring
Eli Lilly, Lilly Korea, Gateway Lab Korea, Songdo, Tune Labs, AI drug discovery, Korean biotech startups
Healio, Healio AI, NPACE, Nurse Practitioner Associates for Continuing Education, continuing medical education, clinician education
Niagen Bioscience, Niagen Plus, clinician-directed telehealth, remote intake, provider consultation, prescription shipment, NAD+
QIAGEN, NVIDIA, QIAGEN Digital Insights, BioNeMo, accelerated computing, target identification, biomarker discovery, pathway analysis
Artera, ArteraAI Breast, multimodal AI, ASCO 2026, HR+ breast cancer, node-positive breast cancer, prostate cancer, risk stratification
Medtronic, Galway software hub, Patient Care Systems, cardiac digital health, cardiac device software, European software development
Abbott, Abbott Laboratories, Lingo, diagnostics, wearables, cardiovascular R&D, biomarker devices, data-driven care
Twin Health, GLP-1 Stewardship Model, AI Digital Twin, GLP-1 tapering, GLP-1 discontinuation, obesity care, cardiometabolic care
Bristol Myers Squibb, BMS, Anthropic, Claude, Claude Code, enterprise AI, pharma operations, R&D workflows, manufacturing AI
MyOr, infant food allergy prediction, pediatric prevention, dietitian-led intervention, Australia digital health, Israeli digital health
Department of Health Abu Dhabi, Johnson & Johnson, intelligent surgical network, Polyphonic, Cleveland Clinic Abu Dhabi, PureHealth, Mediclinic, NMC Healthcare
Plus Therapeutics, Ephemeral Technologies, CNS oncology, AI execution platform, radiotherapeutics, CNSide, leptomeningeal metastases, glioblastoma
Continuous glucose monitoring, CGM, glucose tracking, metabolic health, AI wellness, predictive analytics, personalized coaching
Google Co-Scientist, FutureHouse Robin, AI agents, AI co-scientist, drug repurposing, hypothesis generation, biomedical research automation
NHS Shared Business Services, NHS SBS, Healthcare AI Solutions framework, AI procurement, NHS AI, diagnostics AI, robotics, operational efficiency
Parkinson’s disease, COPD, voice biomarkers, sustained vowel recordings, machine learning, SHAP, soft-voting classifier, acoustic features
The Lancet Digital Health, GPT-4o, patient-oriented discharge summaries, patient activation, PAM-13, hospital discharge communication
NEJM AI, predictive AI, therapy ROI, treatment allocation, number needed to treat, NNT, risk-based targeting, response-based targeting
AI scribes, ambient clinical documentation, patient–physician encounters, privacy governance, data retention, consent, AI training data
npj Digital Medicine, iPad eye tracking, EyeLink, oculomotor assessment, Parkinson’s screening, digital biomarkers
FDA-authorized digital therapeutics, DTx, digital therapeutic evidence, pivotal RCTs, real-world evidence, post-market studies
PLOS Digital Health, XGBoost, SCORE2, hypertension, cardiovascular disease prediction, new-onset CVD, risk stratification
DIGITAL HEALTH, lung cancer mortality prediction, Korea National Hospital Discharge Injury Survey, CCI, ACCI, ECI, neural networks
Spina bifida, metaverse healthcare, healthcare transition, adolescent self-management, avatar-based interactions, South Korea
Samsung Electronics, Samsung Health, Health Index, Galaxy Watch, Galaxy Ring, wearable health score, sleep, stress, recovery
European Commission, EU AI screening, cancer screening, cardiovascular disease screening, medical imaging AI, European datasets
Shanghai, City News Service, World Health Assembly, smart healthcare, public health risk identification, knowledge graphs, RAG, multi-agent systems, digital twins
Google AI Search, Google I/O, AI Mode, Gemini 3.5 Flash, agentic search, healthcare information discovery
References
- https://www.digitalhealth.net/2026/05/one-in-seven-use-ai-chatbots-instead-of-seeing-a-doctor-poll-finds/
- https://www.digitalhealthnews.com/apple-rolls-out-latest-health-monitoring-features
- https://www.dongascience.com/en/news/78054
- https://www.healio.com/news/primary-care/20260522/healio-partners-with-npace-to-integrate-ai-in-continuing-education
- https://www.trendhunter.com/amp/trends/cliniciandirected-telehealth-platform
- https://www.digitalhealthnews.com/qiagen-partners-with-nvidia-to-expand-ai-drug-discovery
- https://www.businesswire.com/news/home/20260521757142/en/Artera-Presents-Multiple-ASCO-2026-Abstracts-on-Multimodal-AI-MMAI-Risk-Stratification-and-Treatment-Decisions-in-Cancer
- https://www.mpo-mag.com/breaking-news/medtronic-unveils-european-software-development-hub-in-galway/
- https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/abbott-deepens-digital-health-push-with-new-cardiovascular-d/amp
- https://hitconsultant.net/2026/05/21/twin-health-launches-glp1-stewardship-ai-model/
- https://www.digitalhealthnews.com/bristol-myers-squibb-partners-with-anthropic-to-deploy-claude-across-global-operations
- https://www.australianjewishnews.com/israeli-ai-predicts-baby-allergies-before-they-appear/
- https://gulfnews.com/uae/health/abu-dhabi-launches-intelligent-surgical-network-with-johnson-johnson-1.500550201
- https://www.globenewswire.com/news-release/2026/05/19/3297370/0/en/plus-therapeutics-partners-with-ephemeral-technologies-to-deploy-ai-execution-platform-for-cns-oncology.html
- https://www.techrepublic.com/article/news-ai-glucose-monitors-wellness-wearables/
- https://arstechnica.com/science/2026/05/two-ai-based-science-assistants-succeed-with-drug-retargeting-tasks/
- https://www.digitalhealth.net/2026/05/nhs-sbs-launches-900m-healthcare-ai-solutions-framework/
- https://www.nature.com/articles/s41598-026-53409-3
- https://www.thelancet.com/journals/landig/article/PIIS2589-7500(26)00014-2/fulltext
- https://ai.nejm.org/doi/full/10.1056/AIpc2600139
- https://ai.nejm.org/doi/full/10.1056/AIpc2501401
- https://www.nature.com/articles/s41746-026-02753-9
- https://www.nature.com/articles/s41746-026-02737-9
- https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001441
- https://journals.sagepub.com/doi/10.1177/20552076261440650
- https://journals.sagepub.com/doi/10.1177/20552076261455147
- https://www.mk.co.kr/en/business/12055832
- https://www.citynewsservice.cn/articles/cns/health-wellness/general/shanghais-smart-healthcare-practices-shared-at-geneva-conference-empowered-by-ai-zmab375n
- https://www.nature.com/articles/d41586-026-01596-4
- https://blog.google/products-and-platforms/products/search/search-io-2026
- https://ai.google/gemini-for-science/